0001209191-20-008522.txt : 20200211 0001209191-20-008522.hdr.sgml : 20200211 20200211192950 ACCESSION NUMBER: 0001209191-20-008522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200207 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUBINO RICHARD J CENTRAL INDEX KEY: 0001252014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 20599313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 237-5300 MAIL ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-07 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001252014 RUBINO RICHARD J C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 0 1 0 0 Chief Financial Officer Common Stock 2020-02-07 4 F 0 1055 20.49 D 350141 D Common Stock 2020-02-08 4 F 0 1023 20.49 D 349118 D Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock. /s/ John LaRocca, Attorney-in-Fact for Richard J. Rubino 2020-02-11